site stats

Massive bio funding

WebFunding Democratizing Personalized Oncology Massive Bio ( massivebio.com) provides cutting edge concierge advisory services for precision oncology (targeted therapies and immunotherapies) to cancer patients either directly or through channel partners. WebMassive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials that offer new, alternativ … See more Massive Bio is a global cutting-edge advisory service for …

Massive Bio - Products, Competitors, Financials, Employees ...

WebMassive Bio, an artificial intelligence-driven digital platform connecting cancer patients and their community oncologists for clinical trial enrollment, announced a $2.6 million round of funding.. Revo Capital, a European technology venture capital firm, led the funding round with additional participation from the Cavendish Impact Foundation (CIF) through their … WebNov 3, 2024 · NEW YORK-- ( BUSINESS WIRE )-- Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial enrollment, … buy now button example https://uptimesg.com

Massive Bio Reaffirms Global Growth Strategy with Key C-Suite …

WebJan 13, 2024 · Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials, yielding profound improvement in access and match rates, leading to ... WebMassive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials that offer new, alternative, and targeted treatments to … WebMassive Bio, an artificial intelligence-driven digital platform connecting cancer patients and their community oncologists for clinical trial enrollment, announced a $2.6 million round … century chest

Massive Bio Raises $2.6 Million for Oncology Clinical Trial Platform

Category:Massive Bio: Contact Details and Business Profile

Tags:Massive bio funding

Massive bio funding

Massive Bio

WebNov 3, 2024 · The investment brings Massive Bio's total funding since launch to $6.6 million and will enable the biotechnology company to scale to meet the demand in the … WebThe Big Ten Conference Council of Presidents and Chancellors (COPC) voted unanimously on April 11, 2024, to select Tony Petitti as the seventh commissioner in conference history. Commissioner Petitti joins an esteemed lineage of Big Ten Conference Commissioners, beginning with John Griffith (1922-45), Tug Wilson (1945-61), Bill Reed (1961-71 ...

Massive bio funding

Did you know?

WebOct 30, 2024 · www.massivebio.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Other Healthcare Technology Systems … WebNov 3, 2024 · NEW YORK-- ( BUSINESS WIRE )-- Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial enrollment, today announced a $2.6 million round of funding led by Revo Capital with additional participation from Cavendish Impact Foundation (CIF), through their donor advised fund at …

WebNov 29, 2024 · Massive Bio Feb 2015 - Present8 years 3 months New York Making precision oncology and clinical trials available to all cancer patients around the globe, using Artificial Intelligence, Virtual... WebJun 2, 2024 · NEW YORK – Massive Bio said on Thursday that it has raised $9 million in new venture capital. Revo Capital and individual investor Kenan Turnacioglu led the …

Web15 hours ago · The company officially launched Thursday, announcing $158 million from a now-complete Series B funding round that was led by Goldman Sachs Asset Management and saw participation from Cowen Healthcare Investments, Vertex Ventures HC and Alexandria Venture Investments, among others. Keep up with the story. WebMar 15, 2024 · Biotech & Health ElevateBio raises $525M to advance its cell and gene therapy technologies Darrell Etherington @ etherington / 4:59 AM PDT • March 15, 2024 Comment Image Credits: Bloomberg / Getty...

WebJun 2, 2024 · Overview. Organization Name. Massive Bio. Announced Date Jun 2, 2024. Closed On Date Dec 16, 2024. Funding Type Series B. Funding Stage Early Stage Venture. Money Raised $16.5M.

WebMassive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients. Subscribe to our newsletter Receive daily news updates directly in your inbox. buy now button designWebDec 17, 2024 · Massive Bio is a young company working relentlessly to continue its unwavering commitment to creating a world without cancer.” This project has been funded in whole with Federal funds from the... century chartWebJun 10, 2024 · Massive Bio, a startup in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial enrollment, raised $9 million co-led by Revo Capital and Kenan Turnacioglu, Chair of Board of Directors PaigeAI; with additional participation from DEG - Deutsche Investitions- und Entwicklungsgesellschaft mbH, the German … buy now button gifWebMassive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients. Subscribe to our newsletter Receive … buynowbuyright.shopWeb18 hours ago · April 14, 2024. Growth in sub-Saharan Africa (SSA) is expected to slow to 3.6 percent as a “big funding squeeze”, tied to the drying up of aid and access to private finance, hits the region. This is the second consecutive year … century chemical ltdWebDec 15, 2024 · The new hires are an outcome of Massive Bio’s latest $16.5 million funding round, which brought the company’s total raise to $23.3 million from its inception. century chesterfield sofaWebMassive Bio has 5 employees at their 1 location and $6.6 m in total funding,. See insights on Massive Bio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Advanced. ... Massive Bio is a company developing a platform for cancer patients, their doctors, and clinical trials. It offers a ... buy now button image